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Abstract
Background: Respiratory muscle strength has been related to the postoperative outcome of cardiac surgeries. The main 
documented therapeutic purpose of transcutaneous electrical nerve stimulation (TENS) is the reduction of pain, which 
could bring secondary benefits to the respiratory muscles and, consequently, to lung capacities and volumes.
Objectives: The objective of the present study was to evaluate the effectiveness of short-duration transcutaneous 
electrical nerve stimulation (TENS) in the reduction of pain and its possible influence on respiratory muscle strength 
and lung capacity and volumes of patients in the postoperative period of cardiac surgery.  
Methods: Twenty five patients with mean age of 59.9 ± 10.3 years, of whom 72% were men, and homogeneous as 
regards weight and height, were randomly assigned to two groups. One group received therapeutic TENS (n = 13) and 
the other, placebo TENS (n = 12), for four hours on the third postoperative day of cardiac surgery. Pain was analyzed by 
means of a visual analogue scale, and of respiratory muscle strength as measured by maximum respiratory pressures 
and lung capacity and volumes before and after application of TENS.
Results: Short-duration TENS significantly reduced pain of patients in the postoperative period (p < 0.001). Respiratory 
muscle strength (p < 0.001), tidal volume (p < 0.001) and vital capacity (p < 0.05) significantly improved after 
therapeutic TENS, unlike in the placebo group. 
Conclusion: Short-duration TENS proved effective for the reduction of pain and improvement of respiratory muscle 
strength, as well as of lung volumes and capacity. (Arq Bras Cardiol 2010; 94(3):325-331)
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can make physical therapy even slower due to the lack 
of cooperation1,2. The surgical wound pain restricts lung 
expansion to a certain extent, thus favoring respiratory 
complications. Pulmonary complications are the major 
causes of morbidity in the postoperative period of cardiac 
surgery, and can contribute to the reduction of respiratory 
muscle strength, lung volumes and capacity; atelectasis is 
one of the most common of them, affecting approximately 
64% of patients undergoing surgery3-6.
TENS is a modality of low-frequency electric current 
with the therapeutic purpose of reducing pain stimuli. It is 
considered an efficient, easy-to-use, noninvasive, non-toxic 
and relatively low-cost procedure which, however, is poorly 
corroborated by non-controlled randomized studies7-9. Few 
studies report the secondary effects of the use of TENS, and 
most of them are not related to cardiac surgery.
The objective of the present study was to use TENS 
in the postoperative period of cardiac surgery for a short 
period of four hours and also to evaluate its effects on 
pain, respiratory muscle strength, and lung volumes and 
capacity. 
Introduction 
Pain is a physiological response to different body injuries 
and is significant in patients in the postoperative period of 
cardiac surgery. Despite the therapeutic advances achieved, 
the use of adjuvant resources may contribute to a favorable 
outcome. Transcutaneous electrical nerve stimulation (TENS) 
has proven an efficient alternative adjuvant therapy. However, 
its secondary effects are not frequently described in the 
scientific literature. 
Pain in the postoperative period of cardiac surgery is 
an actual, fact and may contribute to worsening of the 
respiratory muscle strength and decrease of lung volumes 
and capacity, thus reducing the number of deep breaths 
and effectiveness of cough, which is indispensable in the 
postoperative period of cardiac surgery. The pain stimulus 
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Methods
This is a prospective randomized clinical trial. The 
individuals were assigned so as to have equal chances 
of belonging to the therapeutic TENS or placebo groups. 
Randomization was made with the use of  a sealed box.
The inclusion criteria were patients aged between 35-
80 years who had undergone elective cardiac surgery via 
longitudinal median sternotomy. The exclusion criteria were 
patients with pacemaker; pregnant women; cognitive or 
intellectual impairment; absence of pain in the postoperative 
period; sensitivity disorders; and patients undergoing any type 
of analgesia in the eight-hour period preceding the beginning 
of the protocol.  
Clinical and functional assessment
In the preoperative period, one day before surgery, the 
patients underwent a clinical assessment as defined by a 
protocol. Their respiratory muscle strength as well as their 
lung volumes and capacities were also evaluated in the 
preoperative period.
On the third postoperative day, when the patients 
returned to the hospital ward, they underwent a pre-
TENS clinical reassessment according to a protocol. In this 
reassessment, pain intensity was verified with the use of  a 
visual analogue scale (VAS); respiratory muscle strength as 
well as lung volumes and capacity were assessed with the 
use of  a compound gauge and a ventilometer. Then, TENS 
was applied for four hours according to the randomized 
groups. By the end of the intervention, the patients were 
reassessed as regards pain, respiratory muscle strength, and 
lung volumes and capacity. 
The following vital signs were monitored during the pre-
TENS and post-TENS phases: respiratory rate (RR, rpm), heart 
rate (HR, bpm), and blood pressure (BP, mmHg).
Transcutaneous electrical nerve stimulation
Therapeutic and placebo TENS were applied with the 
use of  a portable device for transcutaneous electrical nerve 
stimulation (TENS) (TENS DeviceTM, KLD, Amparo, São 
Paulo, Brazil). The electric current was delivered by two 
pairs of adhesive electrodes (10 x 3.5 cm) positioned one 
on each side of the surgical wound in the subclavian region, 
approximately two to three centimeters. The parameters for 
therapeutic TENS were pulse rate of 80 Hz (hertz), pulse 
width of 150 μs (microseconds) and dose in miliamperes 
(mA) adjusted at a sensitive threshold. The placebo TENS 
device underwent modifications in its internal programming: 
the control capacitor of the time constant was changed 
and the active time between pulses was modified from 
330 miliseconds to 33 seconds, in order to prevent an 
analgesic effect. 
The patients adjusted the intensity of stimulation at the 
point at which they felt a “strong”, although yet comfortable, 
prickling sensation, and were told to reduce the intensity if 
they felt uncomfortable.
The treatment and placebo groups were given the same 
instructions. Even though they were not sure whether or not 
they were receiving electric current after some time of use, 
the device could deliver both continuous and intermittent 
current. 
Maximal respiratory pressure test
Respiratory muscle strength was measured according 
to Neder et al’s protocol10 in order to obtain the maximal 
inspiratory (Pi-max) and expiratory pressures (Pe-max).
Pi-max was measured with the use of  a tube with an open 
distal tip through which the individual initially breathed 
normally and was further asked to make a maximal expiration 
until reaching the residual volume. Next, the therapist would 
set the spinning valve so as to occlude the orifice of the 
compound gauge (GerarMed, model MVD300, Gerar®, 
Brazil), with the patient wearing an occlusive nose clip. 
Then, the individual would make a maximal inspiratory effort 
against the occluded airway. During the test, standard verbal 
prompts were given: “Please exhale, inhale. Let the air out, 
now inhale deeply”.
For the Pe-max test, the same tube with an open distal 
extremity was used, through which the individual was 
once again asked to breathe normally; then, they were 
told to perform a maximal inspiration until reaching the 
total lung capacity. The therapist would set the spinning 
valve so as to occlude the orifice of the compound gauge, 
with the occlusive nose clip kept in position. Then, the 
individual would make a maximal expiratory effort against 
the occluded airway, according to the standardized verbal 
prompt “Please inhale, exhale. Please fill your lung with air 
and now force it out”.
The tests were repeated five times at most, and the best 
result of each one of the three tests whose variation was lower 
than 10% was chosen. A two-minute rest was allowed between 
one test and the next.
Assessment of lung volumes and capacity 
The assessment was made with the use of  a ventilometry 
test (Wright ventilometer, model Mark 8, nSpire Health Inc., 
Longmont, RU) to obtain measurements of minute volume 
(MV, L/min), tidal volume (TV, mL) and vital capacity (VC, L). 
The patient was duly positioned, with the back supported 
at approximately 90º, and their nasal airway was occluded 
by a clip; the equipment was fit to the mouth by means 
of a disposable mouthpiece. In order to measure the VC, 
the patient was asked to perform a maximal inspiration 
followed by a slow maximum expiration, close to the residual 
volume. For MV measurement, the patient was asked to 
breathe normally, with effortless inspiratory and expiratory 
movements for one minute, after a two-minute adaptation. 
TV measurement was obtained from the ratio between the 
MV and respiratory rate (RR, rpm).
Pain assessment
Pain was assessed with the use of  a numerical visual 
analogue scale11 (VAS). The patients were told to mark  the 
point that best represented their pain at rest and with cough 
with a cross-sectional line. The assessment was made before 
and after TENS application.
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Analysis of results
Continuous and semi-continuous variables were analyzed 
in the normal curve and defined as non-parametric with the 
use of the K-S (Kolmogorov-Smirnov) distance. Parametric 
data were expressed as mean and standard deviation, and 
non-parametric data as median and quartiles. Categorical data 
were expressed as absolute (n) and relative (%) frequency. 
Results
Twenty five individuals admitted in the ward of the 
University Hospital of Unifesp, with mean age of 59.9 ± 
10.3 years, of whom 18 (72%) were males were selected 
for the sample. The surgeries included in the study were: 18 
myocardial revascularizations, including grafts; 15 saphenous 
veins and 16 internal thoracic arteries; two aortic valve 
replacements; one correction of the ascending aorta; two 
mitral valve replacements; one myxoma; and one correction of 
ASD. The procedure was performed off-pump in eight patients. 
For those undergoing extracorporeal circulation, the operative 
time was 72.2 ± 17.01 minutes. Analysis of data regarding the 
sample pattern revealed that the groups were homogeneous 
in relation to age, weight and height (Table 1).
Results regarding maximal respiratory pressures, lung 
capacity and volumes, and the cardiovascular response in 
the preoperative, pre-TENS, and post-TENS periods were 
observed.
In relation to pain, there was improvement of 40% at 
rest and 42.9% with cough (Figure 1) in the treatment group 
in relation to the placebo group. In the placebo group, no 
statistical difference was found (Table 2). 
As regards lung capacity and volumes (Figure 2), the 
comparison between groups showed that the TV improved by 
16.28% in relation to baseline values when TENS was performed, 
whereas the values of the placebo group worsened by 7.36%, 
with a difference of 23.64% between the groups. In relation to 
the VC, there was an 18.18% improvement in the treatment 
group, and only 3.13% in the placebo group, with a difference 
of 15.05% between the groups. The MV showed a tendency of 
improvement in the treatment group (11.48%) in comparison to 
the placebo group (1.04%), with a difference of 10.44% between 
the groups, whereas the respiratory rate was similar in the two 
groups. Between the pre and post-TENS periods. the VC after 
the application of TENS increased in the treatment group (Figure 
3) in comparison to the placebo group.
The comparison between groups regarding the Pi-max 
and Pe-max variables showed improvement by 23.08% of Pi-
max in the treatment group and worsening by 9.72% in the 
placebo group, with a 32.80% difference between groups. 
Improvement by 25% was observed in Pe-max of the treatment 
group, with no change in the median of the placebo group 
(Figure 4). Maximal respiratory pressures after the use of 
TENS (Figure 5) increased significantly in comparison to the 
placebo group.
Discussion
The effects of transcutaneous electrical nerve stimulation 
(TENS) on acute and chronic pain have been studied since 
the 1970’s. Further studies also analyzed the benefits of TENS 
in pain processes occurring in the postoperative period. This 
prospective randomized study evaluated the effect of TENS on 
the reduction of pain in the postoperative period of cardiac 
surgery. We not only found a positive effect of TENS on pain 
relief, but also improvement of respiratory muscle strength 
and lung capacity and volumes. 
 Corroborating our findings, preliminary studies also showed 
that TENS is effective in the control of mild to moderate pain 
in the postoperative period, and could also be useful in cases 
of severe pain12,13.
Klin et al7, Bayindir et al12, Erdogan et al13 and Benedetti 
et al14 studies evaluated  the benefit of TENS and verified 
that electrostimulation reduced the level of pain in the 
postoperative period and decreased the amount of analgesic 
drugs used in comparison to the placebo or control group.
Bjordal et al15 published a meta-analysis with studies using 
TENS as an analgesic resource in the postoperative period 
Table 1 – Baseline characteristics of patients selected for elective 
cardiac surgery (n=25)
Mean ± SD CV (%)
Age 59.9 ± 10.3 17.9
Height 1.66 ± 0.08 5.18
Weight 71.68 ± 11.63 16.23
Nº (%)
Gender
Male 18 72
Female 7  28  
SD - standard deviation; CV - coefficient of variation.
Statistical method used: Continuous parametric data expressed as mean ± 
standard deviation; categorical or continuous data expressed as Nº, Number of 
patients (% of the total)
Fig. 1 - Comparison of percentage variation of pain with cough and at rest in 
the treatment versus placebo groups.
PAIN C - pain with cough; PAIN R - pain at rest. Statistical method used: non-
parametric data expressed as median and quartiles. ***p<0.001.
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Table 2 – Overall analysis of pain, respiratory muscle strength, lung volumes and capacity, and cardiovascular response in the preoperative, 
pre-TENS, and post-TENS periods of patients in the postoperative period of cardiac surgery
Preoperative Pre-TENS Post-TENS
Mean ± SD Mean ± SD Mean ± SD
Pain
 Pain R 0 ± 0 3.4 ± 1 2.6 ± 1
 Pain C 0 ± 0 6.2 ± 1.5 4.8 ± 1.4
Respiratory muscle strength
 Pi-max (cmH2O) -64.8 ± 27.7 -51.3 ± 23.9 -54.6 ± 22.5
 Pi-max (% expected) 100.74 ± 16.5 83 ± 28 90 ± 35
 Pe-max (cmH2O) 62.6 ± 22.6 43.8 ± 19 48.5 ± 17
 Pe-max (% expected) 106.2 ± 21 75 ± 26 86 ± 28
Lung volumes and capacity
 TV (ml) 494,7 ± 104.5 435.7 ± 81.2 466.4 ± 84.4
 RR (bpm) 16.7 ± 2.4 19.3 ± 2.9 18.8 ± 2.9
 VC (L) 2.5 ± 0.7 1.5 ± 0.5 1.7 ± 0.4
 MV (L/min) 8.1 ± 2.3 8.3 ± 2.1 8.8 ± 1.9
Cardiovascular response
 HR (bpm) 86 ± 16.1 87.8 ± 12.3 89 ± 10.1
 SBP (mmHg) 120.8 ± 18.6 127.2 ± 7.3 125.2 ± 6.5
 DBP (mmHg) 75.5 ± 8.4 73.2 ± 8.5 73.2 ± 8
HR - heart rate; SBP - systolic blood pressure; DBP - diastolic blood pressure; PAIN R - pain at rest; PAIN C - pain with cough; TV - tidal volume; RR - respiratory rate; VC 
- vital capacity; MV-  minute volume; Pi--mzx,maximal inspiratory pressure; Pe--max, maximal expiratory pressure.
Statistical method used: continuous data expressed as mean ± standard deviation.
Fig. 2 – Comparison of percentage variation of lung volumes and capacity of the treatment versus placebo groups after TENS application in the postoperative period 
of cardiac surgery. 
TV - tidal volume; RR - respiratory rate; VC - vital capacity; MV - minute volume; Pi_mzx - maximal inspiratory pressure; Pe-max - maximal expiratory pressure; 
Statistical method used: non-parametric data expressed as median and quartiles; * p<0.05; ** p<0.01; *** p<0.001; ns, non significant.
TV
 - 
tid
al
 v
ol
um
e
RR
 - 
re
sp
ira
to
ry
 ra
te
Placebo Treatment Placebo Treatment
TENS group TENS group
VC
 - 
vi
ta
l c
ap
ac
ity
 
M
V 
- m
in
ut
e 
vo
lu
m
e
Placebo Treatment Placebo Treatment
TENS group TENS group
Arq Bras Cardiol 2010; 94(3) : 325-331
Gregorini et al
Short-duration TENS in the postoperative period of cardiac surgery
328
Original Article
Fig. 3 – Comparison of percentage variation of respiratory muscle strength 
of the treatment versus placebo groups after TENS application in the 
postoperative period of cardiac surgery.
VC - vital capacity; L - liter; Statistical method used: non-parametric data 
expressed as median and quartiles; * p<0.05
Placebo Treatment Placebo Treatment
TENS group TENS group
Fig. 4 - Comparison of  vital capacity (VC) pre and post TENS application
TV - tidal volume; RR - respiratory rate; VC - vital capacity; MV - minute 
volume; Pi-max - maximal inspiratory pressure; Pe-max - maximal expiratory 
pressure; 
Statistical method used: non-paired Student’s t test 
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between 1966 and 2001. In that meta-analysis they showed 
that TENS reduced the use of analgesic medication during 
the first three postoperative days, thus decreasing the side 
effects of the medications, one of which is depression of 
the respiratory center. They also demonstrated an important 
difference in pain assessment in patients undergoing placebo 
versus therapeutic TENS.
In the analysis of respiratory muscle strength, we observed 
that the maximal expiratory pressure increased after the use of 
TENS, thus facilitating the process of pulmonary toilet, mucus 
clearance, and efficacy of cough. The maximal inspiratory 
pressure also improved and this could be related to pain 
reduction, thus providing increased pulmonary ventilation 
and reducing the incidence of atelectasis, which is one of the 
major causes of respiratory complications in the postoperative 
period of cardiac surgeries16.
In our bibliographic survey, no studies correlating the use 
of TENS with respiratory muscle strength were found. Johnson 
et al study17 included 138 patients undergoing cardiac surgery, 
who had their maximal inspiratory and expiratory pressures 
and pulmonary function assessed in two periods: at the day of 
hospital discharge, which occurred on the fifth postoperative 
day, on average, and on the eighth postoperative week. In the 
first analysis, pain, as assessed subjectively, was described as 
mild to moderate. The authors believed that pain could have 
been the limiting factor for the patients to perform maximum 
effort. On the eighth week, the patients still presented 
reduced respiratory pressures and pulmonary function in 
comparison to baseline levels, and the authors presumed 
that these findings could be related to muscle weakness in 
the postoperative period. 
Lock et al18 and Belle et al19 evaluated the respiratory 
pressures and pulmonary function in the first, sixth and eighth 
postoperative weeks of cardiac surgery, and they also found a 
significant reduction in respiratory pressures in the first week. 
However, Belle et al19 studied patients in the sixth week and 
found that pressure levels had returned to baseline levels, 
but the pulmonary function was still reduced. Lock et al18, in 
turn, demonstrated that respiratory pressures and pulmonary 
function remained reduced even in the second analysis carried 
Fig. 5 – Comparison of maximal respiratory pressures (Pi_max and Pe_max)  pre and post TENS application
Pi_max - maximal inspiratory pressure; Pe-max - maximal expiratory pressure; p<0.001
Statistical method used: non-paired Student’s t test 
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out in the eighth postoperative week. The authors consider 
the possible occurrence of trauma to the costoverterbral 
joints, thus producing reflex inhibition of intercostal muscle 
contraction, causing  the rib cage to be unable to resist the 
inward force of diaphragmatic contraction. 
Changes in lung volumes and capacity of patients 
undergoing cardiac surgery account, to a great extent, for the 
morbidity of these patients6. Atelectases are the most frequent 
complications4,20,21, resulting from decreased functional 
residual capacity that leads to hypercapnia and hypoxia5,22, 
from rib cage changes17, and from the cephalad displacement 
of the diaphragm. Changes in the respiratory mechanics23 may 
also occur due to increased airway resistance, postoperative 
pain24, paresis of the phrenic nerve25, and others. 
In this study, we sought to study the relationship between 
pain and lung capacity and volumes in the postoperative period 
of cardiac surgery. We could observe that, after the use of TENS 
for four hours, the patients presented improvement of pain, 
so that they could perform deeper inspiratory movements, 
thus obtaining improved vital capacity in comparison to the 
placebo group. Also, the tidal volume increased by 23% in 
comparison to the placebo group, whereas the respiratory rate 
(RR) tended to decrease after the use of TENS, thus resulting 
in a slight improvement of the minute volume. These data 
corroborate those of other studies such as Ali et al3, which 
reported improved VC after the use of TENS; Stratton and 
Smith26, which also found improved forced vital capacity (FVC) 
after the use of TENS; and Cipriano27, which demonstrated 
the positive effects of TENS on pulmonary and musculosketal 
functions of patients in the postoperative period of cardiac 
surgery. Erdogan et al13 conducted a controlled prospective 
randomized double-blind study evaluating the efficacy of 
TENS in thoracic surgery, and demonstrated beneficial effects 
of electrostimulation in their patients, so that they needed less 
opioid analgesics and their cough effort was increased during 
physical therapy.
There can be, however, important limitations to the 
present study: the sample was relatively small due to the 
difficulty of including patients undergoing the surgical 
procedure with the same medical team and using the 
same anesthetic protocol; the fixed and reduced time of 
utilization of the current in order to be more adequate to 
reality; and the hospital routine. Another limitation refers 
to the cross-sectional design chosen for the analysis of the 
third postoperative day, since the correct evaluation of TENS 
application depended on the patients not being receiving 
intravenous analgesics and being already cognitively able 
to answer a questionnaire. Also, one other limitation was 
the fact that our sample included several types of cardiac 
surgeries homogenized as to the type of surgical incision 
(longitudinal median sternotomy). 
We believe that our findings will encourage and disseminate 
the use of low-cost adjuvant therapies in the postoperative 
period of cardiovascular surgery, thus positively contributing 
to a better clinical and functional outcome.
Conclusions
Short-duration transcutaneous electrical nerve stimulation 
is useful in the control of pain in the postoperative period of 
cardiac surgery. It also provides improved respiratory muscle 
strength and increased lung capacity and volumes. 
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